Abstract:Objective To investigate the protective effect of thymopentin on renal function in patients with acute renal injury caused by sepsis. Methods Fifty-four cases of acute renal injury caused by sepsis in the Third Affiliated Hospital of Soochow University from June 2015 to December 2016 were selected, and randomly divided into an observation group and a control group, each group had 27 cases. The patients in the control group were treated with routine therapy. The patients in the observation group were subcutaneously injected with 10 mg thymopentin on the basis of routine therapy once a day for 1 week. Results Before treatment, there was no significant difference in tumor necrosis factor α (TNF-α), interleukin 10 (IL-10), C-reactive protein (CRP), procalcitonin (PCT), serum creatinine (Scr) or blood urea nitrogen (BUN) level, T-lymphocyte subset CD3+ cells, CD4+ cells or CD8+ cells or CD4+/CD8+ ratio between the two groups (P > 0.05). After treatment, CD3+, CD4+, CD8+ lymphocytes and CD4+ / CD8+ ratio in the observation group were significantly higher than those in the control group (P < 0.05); whereas the levels of TNF-α, IL-10, CRP and PCT, Scr and BUN in the observation group were significantly lower than those in the control group (P < 0.05). Conclusions Thymopentin can significantly restore and improve the cellular immune function of sepsis patients, and has important clinical effect of renal protection in patients with acute renal injury caused by sepsis.